Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia

A Systematic Review

Jun Ku Chung, Shinichiro Nakajima, Eric Plitman, Yusuke Iwata, Danielle Uy, Philip Gerretsen, Fernando Caravaggio, M. Mallar Chakravarty, Ariel Graff-Guerrero

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Current literature suggests that the pathology of schizophrenia (SCZ) has developmental origins. However, the neurodevelopmental theory of SCZ cannot solely explain progressive neurodegenerative processes in the illness. There is evidence of accelerated cognitive decline and increased risk of dementia in elderly patients with SCZ. Investigating β-amyloid (Aβ), we conducted a systematic review focusing on Aβ in patients with SCZ. An OVID literature search using PsychINFO, Medline, and Embase databases was conducted, looking for studies that compared Aβ levels between patients with SCZ and either elderly control subjects, patients with Alzheimer disease (AD), or patients with other psychiatric illnesses. Among 14 identified studies, 11 compared Aβ between SCZ and elderly control subjects, 7 between SCZ and AD, and 3 between SCZ and other psychiatric illnesses. As a result, no evidence was found suggesting that Aβ levels differ in patients with SCZ from elderly control subjects or patients with other psychiatric illnesses. All seven studies reported lower cortical Aβ in patients with SCZ than patients with AD. Furthermore, three of the four studies, which investigated the relationship between Aβ and cognitive impairment in SCZ, observed no association between two factors. The limitations of the included studies are small sample sizes, the inclusion of cerebrospinal fluid Aβ or postmortem plaques rather than cortical Aβ assessment in vivo, and the investigation of different brain regions. In conclusion, Aβ deposition is not associated with cognitive decline in late-life SCZ. Future studies should investigate other neurodegenerative indicators in SCZ to better understand the pathophysiologic mechanisms underlying this illness.

Original languageEnglish
Pages (from-to)923-939
Number of pages17
JournalAmerican Journal of Geriatric Psychiatry
Volume24
Issue number10
DOIs
Publication statusPublished - 2016 Oct 1

Fingerprint

Amyloid
Schizophrenia
Psychiatry
Cognitive Dysfunction
Alzheimer Disease
Sample Size
Cerebrospinal Fluid
Dementia
Databases
Pathology

Keywords

  • Alzheimer disease
  • cognitive decline
  • neurodegeneration
  • schizophrenia
  • β-Amyloid

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia : A Systematic Review. / Chung, Jun Ku; Nakajima, Shinichiro; Plitman, Eric; Iwata, Yusuke; Uy, Danielle; Gerretsen, Philip; Caravaggio, Fernando; Chakravarty, M. Mallar; Graff-Guerrero, Ariel.

In: American Journal of Geriatric Psychiatry, Vol. 24, No. 10, 01.10.2016, p. 923-939.

Research output: Contribution to journalReview article

Chung, JK, Nakajima, S, Plitman, E, Iwata, Y, Uy, D, Gerretsen, P, Caravaggio, F, Chakravarty, MM & Graff-Guerrero, A 2016, 'Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review', American Journal of Geriatric Psychiatry, vol. 24, no. 10, pp. 923-939. https://doi.org/10.1016/j.jagp.2016.03.013
Chung, Jun Ku ; Nakajima, Shinichiro ; Plitman, Eric ; Iwata, Yusuke ; Uy, Danielle ; Gerretsen, Philip ; Caravaggio, Fernando ; Chakravarty, M. Mallar ; Graff-Guerrero, Ariel. / Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia : A Systematic Review. In: American Journal of Geriatric Psychiatry. 2016 ; Vol. 24, No. 10. pp. 923-939.
@article{4b3af03f49194e5993d0b5c08348acf9,
title = "Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review",
abstract = "Current literature suggests that the pathology of schizophrenia (SCZ) has developmental origins. However, the neurodevelopmental theory of SCZ cannot solely explain progressive neurodegenerative processes in the illness. There is evidence of accelerated cognitive decline and increased risk of dementia in elderly patients with SCZ. Investigating β-amyloid (Aβ), we conducted a systematic review focusing on Aβ in patients with SCZ. An OVID literature search using PsychINFO, Medline, and Embase databases was conducted, looking for studies that compared Aβ levels between patients with SCZ and either elderly control subjects, patients with Alzheimer disease (AD), or patients with other psychiatric illnesses. Among 14 identified studies, 11 compared Aβ between SCZ and elderly control subjects, 7 between SCZ and AD, and 3 between SCZ and other psychiatric illnesses. As a result, no evidence was found suggesting that Aβ levels differ in patients with SCZ from elderly control subjects or patients with other psychiatric illnesses. All seven studies reported lower cortical Aβ in patients with SCZ than patients with AD. Furthermore, three of the four studies, which investigated the relationship between Aβ and cognitive impairment in SCZ, observed no association between two factors. The limitations of the included studies are small sample sizes, the inclusion of cerebrospinal fluid Aβ or postmortem plaques rather than cortical Aβ assessment in vivo, and the investigation of different brain regions. In conclusion, Aβ deposition is not associated with cognitive decline in late-life SCZ. Future studies should investigate other neurodegenerative indicators in SCZ to better understand the pathophysiologic mechanisms underlying this illness.",
keywords = "Alzheimer disease, cognitive decline, neurodegeneration, schizophrenia, β-Amyloid",
author = "Chung, {Jun Ku} and Shinichiro Nakajima and Eric Plitman and Yusuke Iwata and Danielle Uy and Philip Gerretsen and Fernando Caravaggio and Chakravarty, {M. Mallar} and Ariel Graff-Guerrero",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.jagp.2016.03.013",
language = "English",
volume = "24",
pages = "923--939",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia

T2 - A Systematic Review

AU - Chung, Jun Ku

AU - Nakajima, Shinichiro

AU - Plitman, Eric

AU - Iwata, Yusuke

AU - Uy, Danielle

AU - Gerretsen, Philip

AU - Caravaggio, Fernando

AU - Chakravarty, M. Mallar

AU - Graff-Guerrero, Ariel

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Current literature suggests that the pathology of schizophrenia (SCZ) has developmental origins. However, the neurodevelopmental theory of SCZ cannot solely explain progressive neurodegenerative processes in the illness. There is evidence of accelerated cognitive decline and increased risk of dementia in elderly patients with SCZ. Investigating β-amyloid (Aβ), we conducted a systematic review focusing on Aβ in patients with SCZ. An OVID literature search using PsychINFO, Medline, and Embase databases was conducted, looking for studies that compared Aβ levels between patients with SCZ and either elderly control subjects, patients with Alzheimer disease (AD), or patients with other psychiatric illnesses. Among 14 identified studies, 11 compared Aβ between SCZ and elderly control subjects, 7 between SCZ and AD, and 3 between SCZ and other psychiatric illnesses. As a result, no evidence was found suggesting that Aβ levels differ in patients with SCZ from elderly control subjects or patients with other psychiatric illnesses. All seven studies reported lower cortical Aβ in patients with SCZ than patients with AD. Furthermore, three of the four studies, which investigated the relationship between Aβ and cognitive impairment in SCZ, observed no association between two factors. The limitations of the included studies are small sample sizes, the inclusion of cerebrospinal fluid Aβ or postmortem plaques rather than cortical Aβ assessment in vivo, and the investigation of different brain regions. In conclusion, Aβ deposition is not associated with cognitive decline in late-life SCZ. Future studies should investigate other neurodegenerative indicators in SCZ to better understand the pathophysiologic mechanisms underlying this illness.

AB - Current literature suggests that the pathology of schizophrenia (SCZ) has developmental origins. However, the neurodevelopmental theory of SCZ cannot solely explain progressive neurodegenerative processes in the illness. There is evidence of accelerated cognitive decline and increased risk of dementia in elderly patients with SCZ. Investigating β-amyloid (Aβ), we conducted a systematic review focusing on Aβ in patients with SCZ. An OVID literature search using PsychINFO, Medline, and Embase databases was conducted, looking for studies that compared Aβ levels between patients with SCZ and either elderly control subjects, patients with Alzheimer disease (AD), or patients with other psychiatric illnesses. Among 14 identified studies, 11 compared Aβ between SCZ and elderly control subjects, 7 between SCZ and AD, and 3 between SCZ and other psychiatric illnesses. As a result, no evidence was found suggesting that Aβ levels differ in patients with SCZ from elderly control subjects or patients with other psychiatric illnesses. All seven studies reported lower cortical Aβ in patients with SCZ than patients with AD. Furthermore, three of the four studies, which investigated the relationship between Aβ and cognitive impairment in SCZ, observed no association between two factors. The limitations of the included studies are small sample sizes, the inclusion of cerebrospinal fluid Aβ or postmortem plaques rather than cortical Aβ assessment in vivo, and the investigation of different brain regions. In conclusion, Aβ deposition is not associated with cognitive decline in late-life SCZ. Future studies should investigate other neurodegenerative indicators in SCZ to better understand the pathophysiologic mechanisms underlying this illness.

KW - Alzheimer disease

KW - cognitive decline

KW - neurodegeneration

KW - schizophrenia

KW - β-Amyloid

UR - http://www.scopus.com/inward/record.url?scp=84994908881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994908881&partnerID=8YFLogxK

U2 - 10.1016/j.jagp.2016.03.013

DO - 10.1016/j.jagp.2016.03.013

M3 - Review article

VL - 24

SP - 923

EP - 939

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 10

ER -